ISKRA Trademark

Trademark Overview


On Wednesday, September 6, 2017, a trademark application was filed for ISKRA with the United States Patent and Trademark Office. The USPTO has given the ISKRA trademark a serial number of 79224919. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, September 7, 2018. This trademark is owned by Obschestvo s ogranichennoi otvetstvennostyu "NAUCHNO-PROIZVODSTVENNAYA FIRMAMATERIA MEDICA HOLDING". The ISKRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment of psychoorganic syndrome, neuropsychiatrie and psychiatric diseases, nervous system disorders, Alzheimer disease, parkinson disease, vertigo of different origin, cardiovascular diseases, stroke, cerebrovascular stroke, vegetative-vascular dystonia, neurodegenerative diseases, neuroinfections, somatoform autonomic dysfunction, atherosclerosis, attention deficit disorder, diseases followed by abnormal changes in bioelectrical characteristics of the brain, congestive heart failure, hyperpiesis, neuroticism, psychosomatic disease, stress disorders, asthenic syndrome, neurotoxicosis and obesity; pharmaceutical and veterinary preparations for use in the prevention of parasitic infections, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, fungal infections, viral infections, parainfluenza, adenovirus, respiratory syncytial virus, coronavirus, labially he...
iskra

General Information


Serial Number79224919
Word MarkISKRA
Filing DateWednesday, September 6, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, September 7, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment of psychoorganic syndrome, neuropsychiatrie and psychiatric diseases, nervous system disorders, Alzheimer disease, parkinson disease, vertigo of different origin, cardiovascular diseases, stroke, cerebrovascular stroke, vegetative-vascular dystonia, neurodegenerative diseases, neuroinfections, somatoform autonomic dysfunction, atherosclerosis, attention deficit disorder, diseases followed by abnormal changes in bioelectrical characteristics of the brain, congestive heart failure, hyperpiesis, neuroticism, psychosomatic disease, stress disorders, asthenic syndrome, neurotoxicosis and obesity; pharmaceutical and veterinary preparations for use in the prevention of parasitic infections, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, fungal infections, viral infections, parainfluenza, adenovirus, respiratory syncytial virus, coronavirus, labially herpes, genital herpes, chicken pox, herpes zoster, infectious mononucleosis, intestinal infections of viral etiology, including calicivirus, adenovirus, coronavirus, rotavirus, enteroviruses, enteroviral and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis, bacterial infections, pseudotuberculosis, whooping cough, yersiniosis, pneumonia; pharmaceutical and veterinary preparations for use in the prevention of bacterial complications of viral infections, prevention of super bacterial infection; pharmaceutical preparations, namely, antihistamines; pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations, namely, psychotropics; pharmaceutical preparations for the treatment of erectile dysfunction, benign prostatic hyperplasia, prostatitis, dysuric disorders, autonomic disturbances of menopause; pharmaceutical preparations for improving digestion and reducing flatulence; pharmaceutical preparations for the treatment of irritable bowel syndrome, functional gastrointestinal disorders; pharmaceutical preparations, namely, anticonvulsants; pharmaceutical preparations, namely, antianxiety preparations; pharmaceutical preparations, namely, cough treatment preparations; pharmaceutical preparations, namely, preparations for the treatment of respiratory tract infection; pharmaceutical preparations for the treatment of rheumatic arthritis, osteoarthrosis, arthropathy, nonspecific ulcerative colitis; pharmaceutical antihypoxic preparations for use in the treatment of respiratory, pulmonary and circulatory diseases; pharmaceutical and veterinary preparations, namely, antioxidants; pharmaceutical nootropic preparations for use in the improvement of cognitive functions, for use in the treatment of memory diseases and disorders; pharmaceutical vasoprotective preparations for use in the treatment of blood disorders, hemorrhoids, varicose veins and vascular diseases; pharmaceutical antihyperglycemic preparations for use in the treatment of elevated levels of glucose in the blood and elevated levels of glycated hemoglobin in the blood; pharmaceutical preparations for the treatment of alcohol and nicotine addiction; homeopathic supplements; food for babies; dietary supplements for humans and animals; capsules sold empty for medicines; cachets for pharmaceutical purposes, namely, flat capsules sold empty for enclosing unpleasant-tasting pharmaceuticals; appetite suppressant pills

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 17, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameObschestvo s ogranichennoi otvetstvennostyu "NAUCHNO-PROIZVODSTVENNAYA FIRMAMATERIA MEDICA HOLDING"
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRU-127473 Moscow
RU

Trademark Events


Event DateEvent Description
Friday, September 27, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 9, 2019FINAL DISPOSITION NOTICE SENT TO IB
Saturday, September 7, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 28, 2019NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 12, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 12, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, September 7, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, September 7, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, February 16, 2018REFUSAL PROCESSED BY IB
Thursday, February 1, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 1, 2018REFUSAL PROCESSED BY MPU
Thursday, January 25, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 24, 2018NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, January 17, 2018ASSIGNED TO EXAMINER
Wednesday, January 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 16, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 11, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB